Mallinckrodt plc Stock News

Drugmakers have begun shipping copycat versions of Takeda Pharmaceutical's drug Vyvanse, which is expected to offset the ongoing shortage of the ADHD medicine in the United States.

Mallinckrodt PLC made it official Monday, with the Dublin, Ireland-based drugmaker filing for bankruptcy for the second time in three years after struggling to make settlement payments for its role in

Drugmaker Mallinckrodt on Monday said the company and some of its units have filed for a second bankruptcy in 3 years in the U.S., with the newest restructuring plan set to reduce its debt by about $1

Mallinckrodt PLC (NYSE:MNK) said it plans to initiate voluntary prepackaged Chapter 11 bankruptcy proceedings in the US in a matter of days to give it room to restructure its debt and reduce the amou

Mallinckrodt (NYSEMKT: MNK ) stock isn't doing so hot on Wednesday after the pharmaceutical company gets ready for another bankruptcy filing. A press release from Mallinckrodt notes that it's going to

Mallinckrodt is planning to start bankruptcy proceedings in the coming days, the U.S. drugmaker said on Wednesday, as it struggles to make required settlement payments for lawsuits alleging that it he

Mallinckrodt PLC MNK, +5.09% said Wednesday it has entered a Restructuring Support Agreement with most of its first and second lien debtholders and the Opioid Master Disbursement Trust II on the terms

2023 has unfolded as a pivotal year for investors and traders alike, specifically those keen on harnessing the potential of penny stocks. These stocks, often priced below $5, present unique opportunit

Drugmaker Mallinckrodt is talking to hedge funds about filing for bankruptcy and avoiding payments intended to help people addicted to opioids, the Wall Street Journal reported on Wednesday.

Shares of Mallinckrodt PLC MNK, +4.35% rose 5.5% in afternoon trading Friday, after the drugmaker disclosed that it will once again delay the $200 million opioid-settlement payment by a week, followin

Mallinckrodt PLC shares MNK, -5.26% surged 9% in the premarket trading after the drug maker and distributor said it was open to proposed transactions from debt holders as it keeps delaying a payment u

Mallinckrodt PLC MNK shares surged in the extended session Thursday after the Dublin-based drug maker and distributor said it was open to proposed transactions as it keeps delaying a payment under an

Drug maker Mallinckrodt MNK, on Monday said it paid roughly $17 million in interest that was due last Tuesday, as it tries to keep up with bill payments following a $1.7 billion opioid settlement foll

Mallinckrodt PLC MNK, -15.69% disclosed Friday that it has decided to further delay the $200 million opioid-settlement payment by a week. The payment was originally due on June 16, before payment was

Generic-drug maker Mallinckrodt MNK, +17.69% on Wednesday said it set aside more than $3.4 million in executive retention bonuses in the event of a possible filing for yet another bankruptcy. The move